Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Clin Cancer Res. 2023 Sep 1;29(17):3329–3339. doi: 10.1158/1078-0432.CCR-23-0709

Figure 2:

Figure 2:

Coronal and axial 18F-Flurodeoxyglucose positron emission tomography (FDG-PET) scan images for patient who had confirmed partial response. Left panel shows the disease extent at baseline (pre-cycle 1) and the right panel shows the response at the pre-cycle 3 timepoint. The large conglomerate of highly FDG avid masses along the pleural surface are significantly reduced. The blue arrowhead symbol shows physiological uptake in cardiac muscle.